Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the move

Stock decliners:

AstraZeneca shares
AZN,
+1.02%
fell 6%. The U.K. drugmaker said its datopotamab deruxtecan treatment showed positive results in patients with advanced non-small cell lung cancer in a clinical Phase 3 trial. Analysts at UBS however pointed out the company did not quantify the progression-free benefit, which it usually does. “We suspect the PFS hazard ratio is acceptable but not great,” they added.

Shares of Tattooed Chef Inc.
TTCF,
+1.11%,
a maker of plant-based food, plummeted 38.6% after hours on Friday after the company said that it plans to file for Chapter 11 bankruptcy protection and pursue a sale of its assets.

Shares of Chemours Co.
CC,
+2.79%
dropped more than 2% in the extended session Friday after the chemicals company said it would have to pay the lion’s share of a “forever chemicals” settlement alongside DuPont de Nemours Inc.
DD,
+0.82%
and Corteva Inc.
CTVA,
-0.69%